US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 8.840
  • +0.240+2.79%
Close Jul 23 16:00 ET
  • 8.840
  • 0.0000.00%
Post 16:03 ET
549.44MMarket Cap-5490P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 13, 2024

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-0.43

-4.88%
Analyst Rating

Strong Buy

Jul 19, 2024

Fulcrum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 117.750K--
--2024/Q2-- / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--
Feb 27, 20242023/Q4871.000K / 394.800K--
Nov 7, 20232023/Q3759.000K / 1.052M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 117.750K--
--2024/Q2-- / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--
Feb 27, 20242023/Q4871.000K / 394.800K--
Nov 7, 20232023/Q3759.000K / 1.052M--

Unlock Free Earnings Estimates

Fulcrum Therapeutics Earnings Reports

  • Fulcrum Therapeutics | 10-Q: Quarterly report

    May 13 07:19 ET

  • Fulcrum Therapeutics | 10-K: Annual report

    Feb 27 16:10 ET

  • Fulcrum Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 07:05 ET

  • Fulcrum Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 07:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 19, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      0.00%

    • Sell

      11.11%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg